top of page
Search

Plasma Expander Market Furnishes Information on Market Share, Market Trends, and Market Growth

  • charvireportprime
  • Apr 13, 2024
  • 4 min read

Executive Summary


Executive Summary:

The Plasma Expander market research report provides insights into market conditions, trends, and geographical spread across regions like North America (NA), Asia-Pacific (APAC), Europe, the United States (USA), and China. The market is expected to grow at a CAGR of % during the forecasted period.

Market Trends:

The increasing prevalence of chronic diseases, rising demand for surgical procedures, and advancements in healthcare infrastructure are driving the growth of the Plasma Expander market. The market is witnessing a shift towards the adoption of synthetic plasma expanders due to their cost-effectiveness and easy availability. Additionally, the growing geriatric population and increasing awareness about plasma expanders among healthcare professionals are contributing to market growth.

Geographical Spread:

- North America (NA): The region dominates the Plasma Expander market due to the presence of well-established healthcare infrastructure, increasing investments in research and development, and a high prevalence of chronic diseases.

- Asia-Pacific (APAC): The region is witnessing significant growth in the Plasma Expander market due to the rising healthcare expenditure, increasing geriatric population, and growing awareness about the benefits of plasma expanders.

- Europe: The region is experiencing steady growth in the Plasma Expander market, driven by advancements in healthcare technology, increasing healthcare spending, and a growing demand for blood products.

- United States (USA): The USA is a key market for Plasma Expanders, owing to the high prevalence of chronic diseases, well-developed healthcare infrastructure, and increasing adoption of advanced medical technologies.

- China: The market in China is growing rapidly due to the increasing healthcare expenditure, rising healthcare infrastructure development, and a growing focus on improving healthcare quality.

Overall, the Plasma Expander market is expected to witness steady growth across regions, driven by factors like increasing prevalence of chronic diseases, rising demand for surgical procedures, and advancements in healthcare infrastructure. The market is poised for significant expansion in the coming years, with a CAGR of 6.50% during the forecasted period.


Market Segmentation:

This Plasma Expander Market is further classified into Overview, Deployment, Application, and Region. 

In terms of Components, Plasma Expander Market is segmented into:


  • Biogen

  • Kedrion Biopharma

  • CSL Behring

  • Takeda

  • Grifols

  • Pfizer

  • Abbott

  • Bayer

  • BioTime

  • Braun

  • Fresenius Kabi


The Plasma Expander Market Analysis by types is segmented into:


  • Dextran

  • Hydroxyethyl Starch

  • Human Albumin

  • PEGylated Albumin

  • Polyvinylpyrrolidone (PVP)

  • Gelatin


The Plasma Expander Market Industry Research by Application is segmented into:


  • Online Pharmacies

  • Retail Pharmacies

  • Hospital Pharmacies


In terms of Region, the Plasma Expander Market Players available by Region are:

North America:

  • United States

  • Canada


Europe:

  • Germany

  • France

  • U.K.

  • Italy

  • Russia


Asia-Pacific:

  • China

  • Japan

  • South Korea

  • India

  • Australia

  • China Taiwan

  • Indonesia

  • Thailand

  • Malaysia


Latin America:

  • Mexico

  • Brazil

  • Argentina Korea

  • Colombia


Middle East & Africa:

  • Turkey

  • Saudi

  • Arabia

  • UAE

  • Korea



Key Drivers and Barriers in the Plasma Expander Market


Key drivers in the Plasma Expander market include increasing prevalence of chronic diseases leading to a rise in surgeries, growing geriatric population, and advancements in healthcare infrastructure. Barriers include high costs associated with plasma expanders, regulatory challenges, and the risk of adverse reactions in some patients. Challenges faced in the market include limited awareness among healthcare professionals about the benefits of plasma expanders, competition from alternative therapies, and the need for further research to improve the safety and efficacy of these products. Additionally, reimbursement issues and stringent regulatory policies also pose significant challenges for market growth.


Inquire or Share Your Questions If Any Before Purchasing This Report: https://www.reportprime.com/enquiry/pre-order/11337

Competitive Landscape


Among the competitive players in the Plasma Expander market, Biogen stands out as a leading biotechnology company known for its innovative treatments for neurodegenerative diseases. With a strong emphasis on research and development, Biogen has consistently focused on expanding its product portfolio and global presence. The company has shown significant market growth, with a market size of over $10 billion in the plasma expander sector.

CSL Behring, a subsidiary of the global healthcare company CSL Limited, is another key player in the plasma expander market. CSL Behring specializes in plasma-derived and recombinant therapies for rare and serious diseases. The company has a strong presence across multiple therapeutic areas and has experienced steady market growth in recent years. Its sales revenue stands at approximately $ billion.

Fresenius Kabi, a subsidiary of the healthcare giant Fresenius SE, is a prominent player in the plasma expander market, known for its range of products in infusion therapy and clinical nutrition. The company has a strong global presence and has been expanding its market reach through strategic partnerships and acquisitions. Fresenius Kabi's sales revenue is estimated to be around $7.5 billion.

Overall, the Plasma Expander market is highly competitive, with these players and others vying for market share through innovation, strategic collaborations, and expansion into emerging markets. As the demand for plasma expanders continues to rise due to the increasing prevalence of traumatic injuries, surgical procedures, and chronic diseases, these companies are expected to further expand their presence and offerings in the market.


 



 
 
 

Recent Posts

See All

Comments

bottom of page